BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Afonso J, Santos LL, Longatto-Filho A, Baltazar F. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy. Nat Rev Urol 2020;17:77-106. [PMID: 31953517 DOI: 10.1038/s41585-019-0263-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 50] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Zhu H, Wang X. Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma. Front Genet 2022;13:965100. [DOI: 10.3389/fgene.2022.965100] [Reference Citation Analysis]
2 Mortezaee K, Majidpoor J, Kharazinejad E. Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated. Med Oncol 2022;39:193. [PMID: 36071302 DOI: 10.1007/s12032-022-01801-0] [Reference Citation Analysis]
3 Yuen JW, Wu RW, Ching SS, Ng C. Impact of Effective Intravesical Therapies on Quality of Life in Patients with Non-Muscle Invasive Bladder Cancer: A Systematic Review. IJERPH 2022;19:10825. [DOI: 10.3390/ijerph191710825] [Reference Citation Analysis]
4 Sun B, Mullapudi SS, Zhang Y, Neoh KG. Glycosylated phospholipid-coated upconversion nanoparticles for bioimaging of non-muscle invasive bladder cancers. Mikrochim Acta 2022;189:349. [PMID: 36006510 DOI: 10.1007/s00604-022-05411-5] [Reference Citation Analysis]
5 Wang X, Xia Z, Li Z, Zhang C. Development of a SETD2-related immune prognostic signature in clear cell renal cell carcinoma. Medicine (Baltimore) 2022;101:e29561. [PMID: 35945780 DOI: 10.1097/MD.0000000000029561] [Reference Citation Analysis]
6 Xiao Z, Cai Y, Wang X, Hu L, Lin M, Zhu K, Wang Y, Shuai X. Nanodrug simultaneously regulates stromal extracellular matrix and glucose metabolism for effective immunotherapy against orthotopic pancreatic cancer. Nano Today 2022;44:101490. [DOI: 10.1016/j.nantod.2022.101490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ren J, Wu J, Tang X, Chen S, Wang W, Lv Y, Wu L, Yang D, Zheng Y. Ageing- and AAA-associated differentially expressed proteins identified by proteomic analysis in mice. PeerJ 2022;10:e13129. [DOI: 10.7717/peerj.13129] [Reference Citation Analysis]
8 Wei J, Hu M, Du H. Improving Cancer Immunotherapy: Exploring and Targeting Metabolism in Hypoxia Microenvironment. Front Immunol 2022;13:845923. [PMID: 35281061 DOI: 10.3389/fimmu.2022.845923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhou W, Tang X, Huang J, Wang J, Zhao J, Zhang L, Wang Z, Li P, Li R. Dual-imaging magnetic nanocatalysis based on Fenton-like reaction for tumor therapy. J Mater Chem B 2022. [PMID: 35403639 DOI: 10.1039/d1tb02308j] [Reference Citation Analysis]
10 Cai J, Chen Z, Zhang Y, Wang J, Zhang Z, Wu J, Mao J, Zuo X. CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma. Mol Ther Oncolytics 2022;24:755-71. [PMID: 35317519 DOI: 10.1016/j.omto.2022.02.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Zheng Y, Han Y, Sun Q, Li Z. Harnessing anti‐tumor and tumor‐tropism functions of macrophages via nanotechnology for tumor immunotherapy. Exploration. [DOI: 10.1002/exp.20210166] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
12 Hou J, Liang S, Xie Z, Qu G, Xu Y, Yang G, Tang C. An immune-related lncRNA model for predicting prognosis, immune landscape and chemotherapeutic response in bladder cancer. Sci Rep 2022;12:3225. [PMID: 35217715 DOI: 10.1038/s41598-022-07334-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Liu Q. Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer. Front Genet 2021;12:825109. [PMID: 35087575 DOI: 10.3389/fgene.2021.825109] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
14 Qiu F, Liu Q, Xia Y, Jin H, Lin Y, Zhao X. Circ_0000658 knockdown inhibits epithelial-mesenchymal transition in bladder cancer via miR-498-induced HMGA2 downregulation. J Exp Clin Cancer Res 2022;41:22. [PMID: 35031054 DOI: 10.1186/s13046-021-02175-3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Zhang Y, Zhu B, Cai Y, Zhu S, Zhao H, Ying X, Jiang C, Zeng J. Alteration in glycolytic/cholesterogenic gene expression is associated with bladder cancer prognosis and immune cell infiltration. BMC Cancer 2022;22:2. [PMID: 34980012 DOI: 10.1186/s12885-021-09064-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ma X, Yang S, Zhang T, Wang S, Yang Q, Xiao Y, Shi X, Xue P, Kang Y, Liu G, Sun ZJ, Xu Z. Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy. Acta Pharm Sin B 2022;12:451-66. [PMID: 35127398 DOI: 10.1016/j.apsb.2021.05.016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 15.0] [Reference Citation Analysis]
17 Zhou L, Guan Q, Zhou W, Kan J, Dong Y. Ambient synthesis of an iminium-linked covalent organic framework for synergetic RNA interference and metabolic therapy of fibrosarcoma. Chem Sci . [DOI: 10.1039/d2sc02297d] [Reference Citation Analysis]
18 Lu P, Jiang Y, Xia Z. Hsa_circ_0003221 facilitates the malignant development of bladder cancer cells via resulting in the upregulation of DHCR24 by targeting miR-892b. Investig Clin Urol 2022;63:e68. [DOI: 10.4111/icu.20220153] [Reference Citation Analysis]
19 Luo S, Wang W, Feng J, Li R. TEX10 Promotes the Tumorigenesis and Radiotherapy Resistance of Urinary Bladder Carcinoma by Stabilizing XRCC6. J Immunol Res 2021;2021:5975893. [PMID: 34966825 DOI: 10.1155/2021/5975893] [Reference Citation Analysis]
20 Zhang Y, Feng S, Hu G, Fang T, Xie D, Lu Q, Xu Y, Shen L, Ning X. An Adenovirus‐Mimicking Photoactive Nanomachine Preferentially Invades and Destroys Cancer Cells through Hijacking Cellular Glucose Metabolism. Adv Funct Materials 2022;32:2110092. [DOI: 10.1002/adfm.202110092] [Reference Citation Analysis]
21 Luo W, Wang J, Dai X, Zhang H, Qu Y, Xiao W, Ye D, Zhu Y. ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer. Front Oncol 2021;11:754845. [PMID: 34868963 DOI: 10.3389/fonc.2021.754845] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Wei WS, Wang N, Deng MH, Dong P, Liu JY, Xiang Z, Li XD, Li ZY, Liu ZH, Peng YL, Li Z, Jiang LJ, Yao K, Ye YL, Lu WH, Zhang ZL, Zhou FJ, Liu ZW, Xie D, Yu CP. LRPPRC regulates redox homeostasis via the circANKHD1/FOXM1 axis to enhance bladder urothelial carcinoma tumorigenesis. Redox Biol 2021;48:102201. [PMID: 34864630 DOI: 10.1016/j.redox.2021.102201] [Reference Citation Analysis]
23 Corsale AM, Di Simone M, Lo Presti E, Picone C, Dieli F, Meraviglia S. Metabolic Changes in Tumor Microenvironment: How Could They Affect γδ T Cells Functions? Cells 2021;10:2896. [PMID: 34831116 DOI: 10.3390/cells10112896] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Gavriatopoulou M, Paschou SA, Ntanasis-Stathopoulos I, Dimopoulos MA. Metabolic Disorders in Multiple Myeloma. Int J Mol Sci 2021;22:11430. [PMID: 34768861 DOI: 10.3390/ijms222111430] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
25 Gao Z, Wu D, Zheng W, Zhu T, Sun T, Yuan L, Fei F, Fu P. Prognostic value of immune-related lncRNA pairs in patients with bladder cancer. World J Surg Oncol 2021;19:304. [PMID: 34663340 DOI: 10.1186/s12957-021-02419-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Hou CP, Tsui KH, Chang KS, Sung HC, Hsu SY, Lin YH, Yang PS, Chen CL, Feng TH, Juang HH. Caffeic acid phenethyl ester inhibits the growth of bladder carcinoma cells by upregulating growth differentiation factor 15. Biomed J 2021:S2319-4170(21)00141-4. [PMID: 34662721 DOI: 10.1016/j.bj.2021.10.006] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Yang YF, Chuang HW, Kuo WT, Lin BS, Chang YC. Current Development and Application of Anaerobic Glycolytic Enzymes in Urothelial Cancer. Int J Mol Sci 2021;22:10612. [PMID: 34638949 DOI: 10.3390/ijms221910612] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
28 Najafi M, Majidpoor J, Toolee H, Mortezaee K. The current knowledge concerning solid cancer and therapy. J Biochem Mol Toxicol 2021;:e22900. [PMID: 34462987 DOI: 10.1002/jbt.22900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
29 Cormio A, Busetto GM, Musicco C, Sanguedolce F, Calò B, Chirico M, Falagario UG, Carrieri G, Piccoli C, Cormio L. Mitofusin-2 Down-Regulation Predicts Progression of Non-Muscle Invasive Bladder Cancer. Diagnostics (Basel) 2021;11:1500. [PMID: 34441434 DOI: 10.3390/diagnostics11081500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Ferreira JA, Relvas-Santos M, Peixoto A, M N Silva A, Lara Santos L. Glycoproteogenomics: Setting the Course for Next-generation Cancer Neoantigen Discovery for Cancer Vaccines. Genomics Proteomics Bioinformatics 2021:S1672-0229(21)00097-8. [PMID: 34118464 DOI: 10.1016/j.gpb.2021.03.005] [Reference Citation Analysis]
31 Zheng Q, Jia J, Zhou Z, Chu Q, Lian W, Chen Z. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers. DNA Cell Biol 2021;40:848-57. [PMID: 34096793 DOI: 10.1089/dna.2021.0024] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
32 Nie Z, Chen M, Wen X, Gao Y, Huang D, Cao H, Peng Y, Guo N, Ni J, Zhang S. Endoplasmic Reticulum Stress and Tumor Microenvironment in Bladder Cancer: The Missing Link. Front Cell Dev Biol 2021;9:683940. [PMID: 34136492 DOI: 10.3389/fcell.2021.683940] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
33 Liu M, Zheng Q, Chen S, Liu J, Li S. FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma. J Inflamm Res 2021;14:1069-84. [PMID: 33790621 DOI: 10.2147/JIR.S296597] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
34 Troisi J, Colucci A, Cavallo P, Richards S, Symes S, Landolfi A, Scala G, Maiorino F, Califano A, Fabiano M, Silvestre G, Mastella F, Caputo A, D’antonio A, Altieri V. A Serum Metabolomic Signature for the Detection and Grading of Bladder Cancer. Applied Sciences 2021;11:2835. [DOI: 10.3390/app11062835] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
35 Wu XN, Su D, Mei YD, Xu MQ, Zhang H, Wang ZY, Li LL, Peng L, Jiang JY, Yang JY, Li DJ, Cao H, Xia ZW, Zeng WJ, Cheng Q, Zhang N. Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment. Cancer Immunol Immunother 2021;70:2835-50. [PMID: 33659999 DOI: 10.1007/s00262-021-02896-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Chen X, Chen S. LINC00649 promotes bladder cancer malignant progression by regulating the miR‑15a‑5p/HMGA1 axis. Oncol Rep 2021;45:8. [PMID: 33649788 DOI: 10.3892/or.2021.7959] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Wu Z, Wen Z, Li Z, Yu M, Ye G. Identification and prognostic value of a glycolysis-related gene signature in patients with bladder cancer. Medicine (Baltimore) 2021;100:e23836. [PMID: 33545950 DOI: 10.1097/MD.0000000000023836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Xia ZN, Wang XY, Cai LC, Jian WG, Zhang C. IGLL5 is correlated with tumor-infiltrating immune cells in clear cell renal cell carcinoma. FEBS Open Bio 2021;11:898-910. [PMID: 33449444 DOI: 10.1002/2211-5463.13085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
39 Wu S, Kuang H, Ke J, Pi M, Yang DH. Metabolic Reprogramming Induces Immune Cell Dysfunction in the Tumor Microenvironment of Multiple Myeloma. Front Oncol 2020;10:591342. [PMID: 33520703 DOI: 10.3389/fonc.2020.591342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
40 Reiter RJ, Sharma R, Rosales-Corral S. Anti-Warburg Effect of Melatonin: A Proposed Mechanism to Explain its Inhibition of Multiple Diseases. Int J Mol Sci 2021;22:E764. [PMID: 33466614 DOI: 10.3390/ijms22020764] [Cited by in Crossref: 8] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
41 Scholtes MP, de Jong FC, Zuiverloon TCM, Theodorescu D. Role of Bladder Cancer Metabolic Reprogramming in the Effectiveness of Immunotherapy. Cancers (Basel) 2021;13:288. [PMID: 33466735 DOI: 10.3390/cancers13020288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
42 Jeevanandam J, Sabbih G, Tan KX, Danquah MK. Oncological Ligand-Target Binding Systems and Developmental Approaches for Cancer Theranostics. Mol Biotechnol 2021;63:167-83. [PMID: 33423212 DOI: 10.1007/s12033-020-00296-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Mortezaee K. Redox tolerance and metabolic reprogramming in solid tumors. Cell Biol Int 2021;45:273-86. [PMID: 33236822 DOI: 10.1002/cbin.11506] [Cited by in Crossref: 6] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
44 Monteiro WF, Diz FM, Andrieu L, Morrone FB, Ligabue RA, Bernardo-gusmão K, de Souza MO, Schwanke AJ. Waste to health: Ag-LTA zeolites obtained by green synthesis from diatom and rice-based residues with antitumoral activity. Microporous and Mesoporous Materials 2020;307:110508. [DOI: 10.1016/j.micromeso.2020.110508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
45 Kim K, Yang W, Jung Y, Cha J. A new aspect of an old friend: the beneficial effect of metformin on anti-tumor immunity. BMB Rep 2020;53:512-20. [DOI: 10.5483/bmbrep.2020.53.10.149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
46 Quagliariello V, De Laurentiis M, Cocco S, Rea G, Bonelli A, Caronna A, Lombari MC, Conforti G, Berretta M, Botti G, Maurea N. NLRP3 as Putative Marker of Ipilimumab-Induced Cardiotoxicity in the Presence of Hyperglycemia in Estrogen-Responsive and Triple-Negative Breast Cancer Cells. Int J Mol Sci 2020;21:E7802. [PMID: 33096896 DOI: 10.3390/ijms21207802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 3.5] [Reference Citation Analysis]
47 Koti M, Ingersoll MA, Gupta S, Lam CM, Li X, Kamat AM, Black PC, Siemens DR. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622-30. [PMID: 32967818 DOI: 10.1016/j.euo.2020.08.013] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
48 Zhao Y, Ye G, Wang Y, Luo D. MiR-4461 Inhibits Tumorigenesis of Renal Cell Carcinoma by Targeting PPP1R3C. Cancer Biother Radiopharm 2020. [PMID: 32915648 DOI: 10.1089/cbr.2020.3846] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Donskyi IS, Chen Y, Nickl P, Guday G, Qiao H, Achazi K, Lippitz A, Unger WES, Böttcher C, Chen W, Adeli M, Haag R. Self-degrading graphene sheets for tumor therapy. Nanoscale 2020;12:14222-9. [PMID: 32608434 DOI: 10.1039/d0nr02159h] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
50 Li F, Guo H, Wang Y, Liu B, Zhou H. Profiles of tumor-infiltrating immune cells and prognostic genes associated with the microenvironment of bladder cancer. Int Immunopharmacol 2020;85:106641. [PMID: 32470882 DOI: 10.1016/j.intimp.2020.106641] [Cited by in Crossref: 9] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
51 Ono K, Takigawa S, Yamada K. L-Glucose: Another Path to Cancer Cells. Cancers (Basel) 2020;12:E850. [PMID: 32244695 DOI: 10.3390/cancers12040850] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]